Metabolic Syndrome and Preeclampsia

Chesley's Hypertensive Disorders in Pregnancy

Volumn , Issue , 2009, Pages 105-128

  Hubel, Carl A ^a   Roberts, James M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856484607     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374213-1.00007-0     Document Type: Chapter

References (251)

1. C.W.G. Redman, G.P. Sacks and I.L. Sargent (1999) Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180 499-506.
2. J.M. Roberts and C.A. Hubel (1999) Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet 354 788-789.
3. D. Haig (1993) Genetics conflicts in human pregnancy. Q Rev Biol 68 495-532.
4. Y.M. Kim, E. Bujold, T. Chaiworapongsa, et al. (2003) Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obset Gynecol 189 1063-1069.
5. F. Arias, A. Victoria, K. Cho and F. Kraus (1997) Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol 89 265-271.
6. R. Pijnenborg, L. Vercruysse, M. Hanssens and A.F. Van Assche (2007) Trophoblast invasion in pre-eclampsia and other pregnancy disorders. F. Lyall, M. Belfort (Eds) Pre-eclampsia. Etiology and Clinical Practice Cambridge: Cambridge University Press 1-19.
7. L. Suhonen and K. Teramo (1993) Hypertension and pre-eclampsia in women with gestational glucose intolerance. Acta Obstet Gynecol Scand 72 269-272.
8. J.C. King (2006) Maternal obesity, metabolism, and pregnancy outcomes. Annu Rev Nutr 26 271-291.
9. R.B. Ness and J.M. Roberts (1996) Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 175 1365-1370.
10. E. Kylin (1923) Studies of the hypertension-hyperglycemia hyperuricemia syndrome. Zentral-blatt fuer Innere Medizin 44 105-127.
11. G.M. Reaven (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 1595-1607.
12. K.G. Alberti and P.Z. Zimmet (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 539-553.
13. S.M. Grundy (2008) Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 28 629-636.
14. S.M. Grundy (2006) Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 47 1093-1100.
15. B. Gustafson, A. Hammarstedt, C.X. Andersson and U. Smith (2007) Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 27 2276-2283.
16. H. Hauner (2005) Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 64 163-169.
17. P. Holvoet (2008) Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verh K Acad Geneeskd Belg 70 193-219.
18. J. Chudek and A. Wiecek (2006) Adipose tissue, inflammation and endothelial dysfunction. Pharmacol Rep 58(Suppl), 81-88.
19. A.M. Jonk, A.J. Houben, R.T. de Jongh, E.H. Serne, N.C. Schaper and C.D. Stehouwer (2007) Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Physiol (Bethesda) 22 252-260.
20. K.N. Frayn (2005) Obesity and metabolic disease: is adipose tissue the culprit? Proc Nutr Soc 64 7-13.
21. M. Alderman and K.J. Aiyer (2004) Uric acid: role in cardiovascular disease and effects of losartan. Curr Med Res Opin 20 369-379.
22. J. Segura and L.M. Ruilope (2007) Obesity, essential hypertension and renin-angiotensin system. Public Health Nutr 10 1151-1155.
23. S. de Ferranti and D. Mozaffarian (2008) The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 54 945-955.
24. P.D. Gluckman, M.A. Hanson, C. Cooper and K.L. Thornburg (2008) Effect of in utero and early-life conditions on adult health and disease. N Eng J Med 359 61-73.
25. P.L. Hofman, F. Regan, C.A. Jefferies and W.S. Cutfield (2006) Prematurity and programming: are there later metabolic sequelae? Metab Syndr Relat Disord 4 101-112.
26. L. Myatt (2006) Placental adaptive responses and fetal programming. J Physiol 572 25-30.
27. J.M. Armitage, L. Poston and P.D. Taylor (2008) Developmental origins of obesity and the metabolic syndrome: the role of maternal obesity. M. Korbonitis (Eds) Obesity and Metabolism Vol. 36 Basel: Karger 73-84.
28. P.M. Ridker, J.E. Buring, N.R. Cook and N. Rifai (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107 391-397.
29. M.K. Rutter, J.B. Meigs, L.M. Sullivan, R.B. D’Agostino Sr. and P.W. Wilson (2004) C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110 380-385.
30. Q. Qiao, W. Gao, L. Zhang, R. Nyamdorj and J. Tuomilehto (2007) Metabolic syndrome and cardiovascular disease. Ann Clin Biochem 44 232-263.
31. R. Kahn (2008) Metabolic syndrome – what is the clinical usefulness? Lancet 371 1892-1893.
32. N. Sattar, A. McConnachie, G. Shaper, et al. (2008) Can metabolic syndromes usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 371 1927-1935.
33. P. Hossain, B. Kawar and M. El Nahas (2007) Obesity and diabetes in the developing world – a growing challenge. N Eng J Med 356 213-215.
34. E.E. Calle, M.J. Thun, J.M. Petrelli, C. Rodriguez and C.W. Heath Jr. (1999) Body-mass index and mortality in a prospective cohort of U.S. adults. N Eng J Med 341 1097-1105.
35. O. Galili, D. Versari, K.J. Sattler, et al. (2007) Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. Am J Physiol Heart Circ Physiol 292 H904-H911.
36. K.J. Mather and A.D. Baron (2006) Vascular dysfunction and obesity. M.K. Robinson, A. Thomas (Eds) Obesity and Cardiovascular Disease London, UK: Taylor & Francis
37. C.A. Hubel (2006) Dyslipidemia and pre-eclampsia. M.A. Belfort, F. Lydall (Eds) Pre-eclampsia – Aetiology and Clinical Practice Cambridge: Cambridge University Press 164-182.
38. R.P. Wildman, P. Muntner, K. Reynolds, A.P. McGinn, S. Rajpathak, J. Wylie-Rosett and M.R. Sowers (2008) The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 168 1617-1624.
39. A.H. Berg and P.E. Scherer (2005) Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96 939-949.
40. J.N. Fain, A.K. Madan, M.L. Hiler, P. Cheema and S.W. Bahouth (2004) Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145 2273-2282.
41. N. Sattar, P. Clark, A. Holmes, M.E. Lean, I. Walker and I.A. Greer (2001) Antenatal waist circumference and hypertension risk. Obstet Gynecol 97 268-271.
42. S. Yamamoto, T. Douchi, N. Yoshimitsu, M. Nakae and Y. Nagata (2001) Waist to hip circumference ratio as a significant predictor of preeclampsia, irrespective of overall adiposity. J Obstet Gynecol Res 27 27-31.
43. M. Adiels, S.O. Olofsson, M.R. Taskinen and J. Boren (2008) Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 28 1225-1236.
44. P. Schonfeld and L. Wojtczak (2008) Fatty acids as modulators of the cellular production of reactive oxygen species. Free Radic Biol Med 45 231-241.
45. L. Wojtczak and P. Schonfeld (1993) Effect of fatty acids on energy coupling processes in mitochondria. Biochim Biophys Acta 1183 41-57.
46. F. Kim, K.A. Tysseling, J. Rice, et al. (2005) Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta. Arterioscler Thromb Vasc Biol 25 989-994.
47. M. Roche, P. Rondeau, N.R. Singh, E. Tarnus and E. Bourdon (2008) The antioxidant properties of serum albumin. FEBS Lett 582 1783-1787.
48. J.L. Vigne, J.T. Murai, B.W. Arbogast, W. Jia, S.J. Fisher and R.N. Taylor (1997) Elevated nonesterified fatty acid concentrations in severe preeclampsia shift the isoelectric characteristics of plasma albumin. J Clin Endocrinol Metab 82 3786-3792.
49. H. Yuan, W.E. Antholine, W.K. Subczynski and M.A. Green (1996) Release of CuPTSM from human serum albumin after addition of fatty acids. J Inorg Biochem 61 251-259.
50. V.E. Kagan, V.A. Tyurin, G.G. Borisenko, et al. (2001) Mishandling of copper by albumin: role in redox-cycling and oxidative stress in preeclampsia plasma. Hypertens Pregnancy 20 221-241.
51. Y.A. Gryzunov, A. Arroyo, J.L. Vigne, et al. (2003) Binding of fatty acids facilitates oxidation of cysteine-34 and converts copper-albumin complexes from antioxidants to prooxidants. Arch Biochem Biophys 413 53-66.
52. A. Picchi, X. Gao, S. Belmadani, B.J. Potter, M. Focardi, W.M. Chilian and C. Zhang (2006) Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res 99 69-77.
53. S. Umemura, N. Nyui, K. Tamura, et al. (1997) Plasma angiotensinogen concentrations in obese patients. Am J Hypertens 10 629-633.
54. F. Massiera, M. Bloch-Faure, D. Ceiler, et al. (2001) Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 15 2727-2729.
55. K.K. Griendling, C.A. Minieri, J.D. Ollerenshaw and R.W. Alexander (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74 1141-1148.
56. S. Rajagopalan, S. Kurz, T. Munzel, M. Tarpey, B. Freeman, K.K. Griendling and D.G. Harrison (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation - Contribution to alterations of vasomotor tone. J Clin Invest 97 1916-1923.
57. H. Zhang, A. Schmeisser, C.D. Garlichs, K. Plotze, U. Damme, A. Mugge and W.G. Daniel (1999) Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc Res 44 215-222.
58. A. Warnholtz, G. Nickenig, E. Schulz, et al. (1999) Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis – Evidence for involvement of the renin-angiotensin system. Circulation 99 2027-2033.
59. D.M. Tham, B. Martin-McNulty, Y.X. Wang, et al. (2002) Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. Physiol Genomics 11 21-30.
60. D.M. Shah (2005) Role of the renin-angiotensin system in the pathogenesis of preeclampsia. Am J Physiol Renal Physiol 288 F614-F625.
61. X. Yang, F. Wang, H. Chang, et al. (2008) Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation. J Hypertens 26 1629-1635.
62. R. Dechend, C. Viedt, D.N. Muller, et al. (2003) AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 107 1632-1639.
63. R. Dechend, D.N. Muller, G. Wallukat, V. Homuth, M. Krause, J. Dudenhausen and F.C. Luft (2005) Activating auto-antibodies against the AT1 receptor in preeclampsia. Autoimmun Rev 4 61-65.
64. R. Dechend, P. Gratze, G. Wallukat, et al. (2005) Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. Hypertension 45 742-746.
65. C.A. Hubel, G. Wallukat, M. Wolf, et al. (2007) Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension 49 612-617.
66. R. Drolet, C. Richard, A.D. Sniderman, et al. (2008) Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond) 32 283-291.
67. I. Harman-Boehm, M. Bluher, H. Redel, et al. (2007) Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 92 2240-2247.
68. C.W. Redman (2008) The endoplasmic reticulum stress of placental impoverishment. Am J Pathol 173 311-314.
69. P.M. Catalano, A.J. Thomas, L.P. Huston and C.M. Fung (1998) Effect of maternal metabolism on fetal growth and body composition. Diabetes Care 21(Suppl 2), B85-90.
70. P.M. Catalano (2007) Increasing maternal obesity and weight gain during pregnancy: the obstetric problems of plentitude. Obstet Gynecol 110 743-744.
71. E. Herrera (2002) Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine 19 43-55.
72. R.H. Knopp, B. Bonet, M.A. Lasuncion, A. Montelongo and E. Herrera (1992) Lipoprotein metabolism in pregnancy. E. Herrera, R.H. Knopp (Eds) Perinatal Biochemistry Boca Raton: CRC Press, Inc. 19-51.
73. P.M. Catalano, E.D. Tyzbir, N.M. Roman, S.B. Amini and E.A. Sims (1991) Longitudinal changes in insulin release and insulin resistance in non-obese pregnant women. Am J Obstet Gynecol 165 1667-1672.
74. J.T. Murai, E. Muzykanskiy and R.N. Taylor (1997) Maternal and fetal modulators of lipid metabolism correlate with the development of preeclampsia. Metabolism 46 963-967.
75. E. Sivan, C.J. Homko, P.G. Whittaker, E.A. Reece, X. Chen and G. Boden (1998) Free fatty acids and insulin resistance during pregnancy. J Clin Endocrinol Metab 83 2338-2342.
76. J.P. Kirwan, S. Hauguel-deMouzon, J. Leqercq, et al. (2002) TNFα is a predictor of insulin resistance in human pregnancy. Diabetes 51 2207-2213.
77. E.A. Ryan (2003) Hormones and insulin resistance during pregnancy. Lancet 362 1777-1778.
78. C.A. Hubel and J.M. Roberts (1999) Lipid metabolism and oxidative stress in preeclampsia. M.D. Lindheimer, J.M. Roberts (Eds) Chesley's Hypertensive Disorders in Pregnancy 2nd ed Stamford, Connecticut: Appleton & Lange 453-486.
79. J.M. Potter and P.J. Nestel (1979) The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol 133 165-170.
80. A. Montelongo, M.A. Lasuncion, L.F. Pallardo and E. Herrera (1992) Longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women. Diabetes 41 1651-1659.
81. J.J. Alvarez, A. Montelongo, A. Iglesias, M.A. Lasuncion and E. Herrera (1996) Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. J Lipid Res 37 299-308.
82. R.A. Coleman (1989) The role of the placenta in lipid metabolism and transport. Semin Perinatol 13 180-191.
83. E. Herrera, M.A. Lasuncion, D.G. Coronado, P. Aranda, P.L. Luna and I. Maier (1988) Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy. Am J Obstet Gynecol 158 1575-1583.
84. A.L. Magnusson-Olsson, S. Lager, B. Jacobsson, T. Jansson and T.L. Powell (2007) Effect of maternal triglycerides and free fatty acids on placental LPL in cultured primary trophoblast cells and in a case of maternal LPL deficiency. Am J Physiol Endocrinol Metab 293 E24-E30.
85. A.L. Magnusson, I.J. Waterman, M. Wennergren, T. Jansson and T.L. Powell (2004) Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. J Clin Endocrinol Metab 89 4607-4614.
86. P. Haggarty (2002) Placental regulation of fatty acid delivery and its effect on fetal growth – a review. Placenta 23(Suppl A), S28-S38.
87. B. Lorentzen and T. Henriksen (1998) Plasma lipids and vascular dysfunction in preeclampsia. Semin Reprod Endocrinol 16 33-39.
88. B. Leeners, W. Rath, S. Kuse, C. Irawan, B. Imthurn and P. Neumaier-Wagner (2006) BMI: new aspects of a classical risk factor for hypertensive disorders of pregnancy. Clin Sci (Lond) 111 81-86.
89. M.I. Cedergren (2004) Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 103 219-224.
90. K. Raatikainen, N. Heiskanen and S. Heinonen (2006) Transition from overweight to obesity worsens pregnancy outcome in a BMI-dependent manner. Obesity (Silver Spring) 14 165-171.
91. A.B. Wallis, A.F. Saftlas, J. Hsia and H.K. Atrash (2008) Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, united States, 1987-2004. Am J Hypertens 21 521-526.
92. M. Wolf, E. Kettyle, L. Sandler, J.L. Ecker, J. Roberts and R. Thadhani (2001) Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol 98 757-762.
93. N.J. Sebire, M. Jolly, J.P. Harris, et al. (2001) Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord 25 1175-1182.
94. T.E. O’Brien, J.G. Ray and W.S. Chan (2003) Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 14 368-374.
95. R.B. Ness and C.A. Hubel (2005) Risk for coronary artery disease and morbid preeclampsia: a commentary. Ann Epidemiol 15 726-733.
96. B. Eskenazi, L. Fenster and S. Sidney (1991) A multivariate analysis of risk factors for preeclampsia. JAMA 266 237-241.
97. J.L. Stone, C.J. Lockwood, G.S. Berkowitz, M. Alvarez, R. Lapinski and R.L. Berkowitz (1994) Risk factors for severe preeclampsia. Obstet Gynecol 83 357-361.
98. J.M. Roberts (2004) Pregnancy-related hypertension. R.K. Creasy, R. Resnick, J.D. Iams (Eds) Maternal-Fetal Medicine 5th ed Philadelphia: Saunders
99. J.M. Catov, R.B. Ness, K.E. Kip and J. Olsen (2007) Risk of early or severe preeclampsia related to pre-existing conditions. Int J Epidemiol 36 412-419.
100. L.M. Bodnar, J.M. Catov, M.A. Klebanoff, R.B. Ness and J.M. Roberts (2007) Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology 18 234-239.
101. V. Belogolovkin, K.A. Eddleman, F.D. Malone, et al. (2007) The effect of low body mass index on the development of gestational hypertension and preeclampsia. J Matern Fetal Neonatal Med 20 509-513.
102. E. Villamor and S. Cnattingius (2006) Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet 368 1164-1170.
103. L.K. Callaway, H.D. McIntyre, M. O’Callaghan, G.M. Williams, J.M. Najman and D.A. Lawlor (2007) The association of hypertensive disorders of pregnancy with weight gain over the subsequent 21 years: findings from a prospective cohort study. Am J Epidemiol 166 421-428.
104. L. Daly (1998) Confidence limits made easy: internal estimation using a substitution method. Am J Epidemiol 147 783-790.
105. R. Kaaja (1998) Insulin resistance syndrome in preeclampsia. Semin Reprod Endocrinol 16 41-46.
106. C.G. Solomon, S.W. Graves, M.F. Greene and E.W. Seely (1994) Glucose intolerance as a predictor of hypertension in pregnancy. Hypertension 23 717-721.
107. C.G. Solomon, J.S. Carroll, K. Okamura, S.W. Graves and E.W. Seeley (1999) Higher cholesterol and insulin levels in pregnancy are associated with increased risk for pregnancy-induced hypertension. Am J Hypertens 12 276-282.
108. M. Wolf, L. Sandler, K. Munoz, K. Hsu, J.L. Ecker and R. Thadhani (2002) First trimester insulin resistance and subsequent preeclampsia: a prospective study. J Clin Endocrinol Metab 87 1563-1568.
109. H. Laivuori, M.J. Tikkanen and O. Ylikorkala (1996) Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab 81 2908-2911.
110. H. Nisell, C. Erikssen, B. Persson and K. Carlstrom (1999) Is carbohydrate metabolism altered among women who have undergone a preeclamptic pregnancy? Gynecol Obstet Invest 48 241-246.
111. A.E. Barden, L.J. Beilin, J. Ritchie, B.N. Walters and C. Michael (1999) Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia? J Hypertens 17 1307-1315.
112. M. Wolf, C.A. Hubel, C. Lam, et al. (2004) Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 89 6239-6243.
113. C.A. Hubel, S. Snaedal, R.B. Ness, L.A. Weissfeld, R.T. Geirsson, J.M. Roberts and R. Arngrímsson (2000) Dyslipoproteinemia in postmenopausal women with a history of eclampsia. Br J Obstet Gynaecol 107 776-784.
114. J.B. Meigs, P.W.F. Wilson, C.S. Fox, R.S. Vasan, D.M. Nathan, L.M. Sullivan and R.B. D’Agostino (2006) Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91 2906-2912.
115. C.L. Haggerty, R.E. Ferrell, C.A. Hubel, N. Markovic, G. Harger and R.B. Ness (2005) Association between allelic variants in cytokine genes and preeclampsia. Am J Obstet Gynecol 193 209-215.
116. C.A. Hubel (1998) Dyslipidemia, iron, and oxidative stress in preeclampsia: Assessment of maternal and feto-placental interactions. Semin Reprod Endocrinol 16 75-92.
117. N. Sattar and I.A. Greer (2002) Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? Br Med J 325 157-160.
118. N. Sattar and I. Greer (1999) Insulin sensitivity in pre-eclampsia. Br J Obstet Gynaecol 106 874-875.
119. B.A. Laraia, L.M. Bodnar and A.M. Siega-Riz (2007) Pregravid body mass index is negatively associated with diet quality during pregnancy. Public Health Nutr 10 920-926.
120. L.M. Bodnar, G. Tang, R.B. Ness, G. Harger and J.M. Roberts (2006) Periconceptional multivitamin use reduces the risk of preeclampsia. Am J Epidemiol 164 470-477.
121. F.M. Stewart, D.J. Freeman, J.E. Ramsay, I.A. Greer, M.J. Caslake and W.R. Ferrell (2007) Longitudinal assessment of maternal endothelial function and markers of inflammation & placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab 92 969-975.
122. H. Ghanim, A. Aljada, D. Hofmeyer, T. Syed, P. Mohanty and P. Dandona (2004) Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 110 1564-1571.
123. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel and A.W. Ferrante Jr. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 1796-1808.
124. G. Charriere, B. Cousin, E. Arnaud, M. Andre, F. Bacou, L. Penicaud and L. Casteilla (2003) Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem 278 9850-9855.
125. B. Cousin, O. Munoz, M. Andre, et al. (1999) A role for preadipocytes as macrophage-like cells. FASEB J 13 305-312.
126. J.C. Challier, S. Basu, T. Bintein, J. Minium, K. Hotmire, P.M. Catalano and S. Haugel-de Mouzon (2008) Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 29 274-281.
127. L.M. Bodnar, R.B. Ness, G.F. Harger and J.M. Roberts (2005) Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol 162 1198-1206.
128. R. Kaaja, H. Laivuori, P. Pulkki, M.J. Tikkanen, V. Hiilesmaa and O. Ylikorkala (2004) Is there any link between insulin resistance and inflammation in established preeclampsia. Metabolism 53 1433-1435.
129. G.P. Sacks, K. Studena, I.I. Sargent and C.W.G. Redman (1998) Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 179 80-86.
130. K. Tsukimori, H. Maeda, K. Ishida, H. Nagata, T. Koyanagi and H. Nakano (1993) The superoxide generation of neutrophils in normal and preeclamptic pregnancies. Obstet Gynecol 81 536-540.
131. K. Tsukimori, K. Fukushima, A. Tsushima and K. Nakano (2005) Generation of reactive oxygen species by neutrophils and endothelial cell injury in normal and preeclamptic pregnancies. Hypertension 46 696-700.
132. I.A. Greer, R. Leask, B.A. Hodson, J. Dawes, D.C. Kilpatrick and W.A. Liston (1991) Endothelin, elastase, and endothelial dysfunction in preeclampsia. Lancet 337 558.
133. J.R. Mellembakken, P. Aukrust, M.K. Olafsen, T. Ueland, K. Hestdal and V. Videm (2002) Activation of leukocytes during the uteroplacental passage in preeclampsia. Hypertension 39 155-160.
134. A.S. Aly, M. Khandelwal, J. Zhao, A.H. Mehmet, M.D. Sammel and S. Parry (2004) Neutrophils are stimulated by syncytiotrophoblast microvillous membranes to generate superoxide radicals in women with preeclampsia. Am J Obstet Gynecol 190 252-258.
135. P. Luppi and J.A. Deloia (2006) Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin Immunol 118 268-275.
136. C.W. Redman and I.L. Sargent (2005) Latest advances in understanding preeclampsia. Science 308 1592-1594.
137. S.W. Walsh (2007) Obesity: a risk factor for preeclampsia. Trends Endocrinol Metab 18 365-370.
138. M.J. Kupferminc, A.M. Peaceman, T.R. Wigton, K.A. Rehnberg and M.L. Socol (1994) Tumor necrosis factor-a is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 170 1752-1759.
139. K.P. Conrad and D.F. Benyo (1997) Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 37 240-249.
140. Y. Hamai, T. Fujii, T. Yamashita, H. Nishina, S. Kozuma, Y. Mikami and Y. Taketani (1997) Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-α levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol 38 89-93.
141. D.F. Benyo, A. Smarason, C.W. Redman, C. Sims and K.P. Conrad (2001) Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 86 2505-2512.
142. S.A. Founds, R.W. Powers, T.E. Patrick, D. Ren, G. Harger, N. Markovic and J.M. Roberts (2008) A comparison of circulating TNF-alpha in obese and lean women with and without preeclampsia. Hypertens Pregnancy 27 573-589.
143. M.C. Henson and V.D. Castracane (2000) Leptin in pregnancy. Biol Reprod 63 1219-1228.
144. A.J. Jakimiuk, P. Skalba, D. Huterski, R. Tarkowski, J. Haczynski and D.A. Magoffin (2003) Leptin messenger ribonucleic acid (mRNA) content in the human placenta at term: relationship to levels of leptin in cord blood and placental weight. Gynecol Endocrinol 17 311-316.
145. H. Laivuori, M.J. Gallaher, L. Collura, et al. (2006) Relationships between maternal plasma leptin, placental leptin mRNA and protein in normal pregnancy, pre-eclampsia and intrauterine growth restriction without pre-eclampsia. Mol Hum Reprod 12 551-556.
146. N. Anim-Nyame, S.R. Sooranna, P.J. Steer and M.R. Johnson (2000) Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and pre-eclampsia. Hum Reprod 15 2033-2036.
147. S.H. de Mouzon, J. Lepercq and P.M. Catalano (2006) The known and unknown of leptin in pregnancy. Am J Obstet Gynecol 194 1537-1545.
148. L.C. Chappell, P.T. Seed, A. Briley, et al. (2002) A longitudinal study of biochemical variables in women at risk of pre-eclampsia. Am J Obstet Gynecol 187 127-136.
149. J.F. McCarthy, D.N. Misra and J.M. Roberts (1999) Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration. Am J Obstet Gynecol 180 731-736.
150. I. Hendler, S.C. Blackwell, S.H. Metha, J.E. Whitty, E. Russell, Y. Sorokin and D.B. Cotton (2005) The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. Am J Obstet Gynecol 193 979-983.
151. M. Murata, H. Kodama, K. Goto, H. Hirano and T. Tanaka (1996) Decreased very-low-density lipoprotein and low-density lipoprotein receptor messenger ribonucleic acid expression in placentas from preeclamptic pregnancies. Am J Obstet Gynecol 175 1551-1556.
152. B. Lorentzen, C.A. Drevon, M.J. Endressen and T. Henriksen (1995) Fatty acid pattern of esterfied and free fatty acids in sera of women with normal and pre-eclamptic pregnancy. Br J Obstet Gynaecol 102 530-537.
153. C.A. Hubel, M.K. McLaughlin, R.W. Evans, B.A. Hauth, C.J. Sims and J.M. Roberts (1996) Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48hours post partum. Am J Obstet Gynecol 174 975-982.
154. M.J. Endresen, B. Lorentzen and T. Henriksen (1992) Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultured endothelial cells. Am J Obstet Gynecol 167 440-447.
155. N. Sattar, A. Bedomir, C. Berry, J. Shepherd, I.A. Greer and C.J. Packard (1997) Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 89 403-408.
156. R. Kaaja, M.J. Tikkanen, L. Viinikka and O. Ylikorkala (1995) Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 85 353-356.
157. B.W. Arbogast, S.C. Leeper, R.D. Merrick, K.E. Olive and R.N. Taylor (1996) Plasma factors that determine endothelial cell lipid toxicity in vitro correctly identify women with preeclampsia in early and late pregnancy. Hypertens Pregnancy 15 263-279.
158. B. Lorentzen, M.J. Endresen, T. Clausen and T. Henriksen (1994) Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertens Pregnancy 13 103-109.
159. E. Gratacos, E. Casals, C. Sanllehy, V. Cararach, P.L. Alonso and A. Fortuny (1996) Variation in lipid levels during pregnancy in women with different types of hypertension. Acta Obstet Gynecol Scand 75 896-901.
160. T. Clausen, S. Djurovic and T. Henriksen (2001) Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia. Br J Obstet Gynaecol 108 1081-1087.
161. B. Lamarche, S. Rashid and G.F. Lewis (1999) HDL metabolism in hypertriglyceridemic states: an overview. Clin Chim Acta 286 145-161.
162. C.A. Hubel, Y. Shakir, M.J. Gallaher, M.K. McLaughlin and J.M. Roberts (1998) Low-density lipoprotein particle size decreases during normal pregnancy in association with triglyceride increases. J Soc Gynecol Invest 5 244-250.
163. C.A. Hubel, F. Lyall, L. Weissfeld, R.E. Gandley and J.M. Roberts (1998) Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. Metabolism 47 1281-1288.
164. H.J. van den Elzen, J.W. Waldimiroff, T.E. Cohen-Overbeek, A.J. de Bruijn and D.E. Grobbee (1996) Serum lipids in early pregnancy and risk of preeclampsia. Br J Obstet Gynaecol 103 117-122.
165. E.B. Magnussen, L.J. Vatten, T.I. Lund-Nilsen, K.A. Salvesen, G. Davey Smith and P.R. Romundstad (2007) Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ 335 978.
166. M.J. Endresen, E. Tosti, H. Heimli, B. Lorentzen and T. Henriksen (1994) Effects of free fatty acids found increased in women who develop pre-eclampsia on the ability of endothelial cells to produce prostacyclin, cGMP and inhibit platelet aggregation. Scand J Clin Lab Invest 54 549-557.
167. J.F. Bilodeau and C.A. Hubel (2003) Current concepts in the use of antioxidants for the treatment of preeclampsia. J Obstet Gynaecol Can 25 742-750.
168. M. Beckman (2006) Cell biology. Great balls of fat. Science 311 1232-1234.
169. S. Martin and R.G. Parton (2006) Lipid droplets: a unified view of a dynamic organelle. Nat Rev Mol Cell Biol 7 373-378.
170. K.J. Winkler, B. Wetzka, M.M. Hoffmann, et al. (2003) Triglyceride-rich lipoproteins are associated with hypertension in preeclampsia. J Clin Endocrinol Metab 88 1162-1166.
171. G.F. Lewis and G. Steiner (1996) Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 12 37-56.
172. C.D. Gardner, S.P. Fortmann and R.M. Krauss (1996) Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276 875-881.
173. B. Lamarche, A. Tchernof, S. Moorjani, B. Cantin, G.R. Dagenais, P.J. Lupien and J.P. Despres (1997) Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Circulation 95 69-75.
174. B. Lamarche, A. Tchernof, P. Mauriege, B. Cantin, G.R. Dagenais, P.J. Lupien and J.P. Despres (1998) Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 279 1955-1961.
175. M.J. Stampfer, R.M. Krauss, J. Ma, P.J. Blanche, L.G. Holl, F.M. Sacks and C.H. Hennekens (1996) A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 276 882-888.
176. K. Silliman, V. Shore and T.M. Forte (1994) Hypertriglyceridemia during late pregnancy is associated with the formation of small dense low-density lipoproteins and the presence of large buoyant high-density lipoproteins. Metabolism 43 1035-1041.
177. L. Belo, M. Caslake, D. Gaffney, A. Santos-Silva, L. Pereira-Leite, A. Quintanilha and I. Rebelo (2002) Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. Atherosclerosis 162 425-432.
178. K. Ogura, T. Miyatake, O. Fukui, T. Nakamura, T. Kameda and G. Yoshino (2002) Low-density lipoprotein particle diameter in normal pregnancy and preeclampsia. J Atheroscler Thromb 9 42-47.
179. A. Wakatsuki, N. Ikenoue, Y. Okatani, K. Shinohara and T. Fukaya (2000) Lipoprotein particles in preeclampsia: susceptibility to oxidative modification. Obstet Gynecol 96 55-59.
180. R.J. Johnson and B.A. Rideout (2004) Uric acid and diet--insights into the epidemic of cardiovascular disease. N Eng J Med 350 1071-1073.
181. E. Garbagnait and M. Boschetti (1994) Uric acid homeostasis in lean and obese girls during pubertal development. Metabolism 43 819-821.
182. J. Lee, D. Sparrow, P.S. Vokonas, L. Landsberg and S.T. Weiss (1995) Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. Am J Epidemiol 142 288-294.
183. M. Mazzali, J. Hughes, Y.G. Kim, et al. (2001) Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38 1101-1106.
184. M. Mazzali, J. Kanellis, L. Han, et al. (2002) Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 282 F991-F997.
185. Y. Shi, J.E. Evans and K.L. Rock (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425 516-521.
186. D. Patschan, S. Patschan, G.G. Gobe, S. Chintala and M.S. Goligorsky (2007) Uric acid heralds ischemic tissue injury to mobilize endothelial progenitor cells. J Am Soc Nephrol 18 1516-1524.
187. J.M. Roberts, L.M. Bodnar, K.Y. Lain, C.A. Hubel, N. Markovic, R.B. Ness and R.W. Powers (2005) Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension 46 1263-1269.
188. R.W. Powers, L.M. Bodnar, R.B. Ness, et al. (2006) Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery. Am J Obstet Gynecol 194 160.
189. A. Many, C.A. Hubel and J.M. Roberts (1996) Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol 174 288-291.
190. S.A. Bainbridge and J.M. Roberts (2008) Uric acid as a pathogenic factor in preeclampsia. Placenta 29(Suppl A), S67-S72.
191. H.M. Eid, H. Arnesen, E.M. Hjerkinn, T. Lyberg and I. Seljeflot (2004) Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. Metabolism 53 1574-1579.
192. R.H. Boger (2003) The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res 59 824-833.
193. A. Fard, C.H. Tuck, J.A. Donis, et al. (2000) Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 20 2039-2044.
194. F. Palm, M.L. Onozato, Z. Luo and C.S. Wilcox (2007) Dimethylanginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol 293 H3227-H3245.
195. J.P. Cooke (2004) Asymmetrical dimethylarginine: the Uber marker? Circulation 109 1813-1818.
196. R.H. Boger (2003) Association of asymmetric dimethylarginine and endothelial dysfunction. Clin Chem Lab Med 41 1467-1472.
197. R.H. Boger and S.M. Bode-Boger (2000) Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases. Semin Thromb Hemost 26 539-545.
198. R.H. Boger, S.M. Bode-Boger, A. Szuba, et al. (1998) Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98 1842-1847.
199. T. Thum, D. Tsikas, S. Stein, et al. (2005) Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol 46 1693-1701.
200. T. Thum and J. Bauersachs (2005) ADMA, endothelial progenitor cells, and cardiovascular risk. Circ Res 97 e84.
201. T. Thum and J. Bauersachs (2005) Spotlight on endothelial progenitor cell inhibitors: short review. Vasc Med 10 S59-64.
202. M.D. Savvidou, A.D. Hingorani, D. Tsikas, J.C. Frolich, P. Vallance and K.H. Nicolaides (2003) Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 361 1511-1517.
203. P.D. Speer, R.W. Powers, M.P. Frank, G. Harger, N. Markovic and J.M. Roberts (2008) Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants. Am J Obstet Gynecol 198 112e1-7.
204. B.M. Sibai, M. Ewell, R.J. Levine, et al. (1997) Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 177 1003-1010.
205. S. Caritis, B. Sibai, J. Hauth, et al. (1998) Low-dose asprin to prevent preeclampsia in women at high risk. N Eng J Med 338 701-705.
206. R. Queiro, A. Weruaga and J.L. Riestra (2002) C4 deficiency state in antiphospholipid antibody-related recurrent preeclampsia evolving into systemic lupus erythematosus. Rheumatol Int 22 126-128.
207. C.M. Boomsma, M.J. Eijkemans, E.G. Hughes, G.H.A. Visser, B.C. Fauser and N.S. Macklon (2006) A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 12 673-683.
208. T.K. Sorensen, M.A. Williams, I.M. Lee, E.E. Dashow, M.L. Thompson and D.A. Luthy (2003) Recreational physical activity during pregnancy and risk of preeclampsia. Hypertension 41 1273-1280.
209. R.B. Ness, N. Markovic, D. Bass, G. Harger and J.M. Roberts (2003) Family history of hypertension, heart disease, and stroke among women who develop hypertension in pregnancy. Obstet Gynecol 102 1366-1371.
210. L.S. Jonsdottir, R. Arngrimsson, R.T. Geirsson, H. Sigvaldason and N. Sigfusson (1995) Death rates from ischemic heart disease in women with a history of hypertensionin pregnancy. Acta Obstet Gynecol Scand 74 772-776.
211. H.U. Irgens, L. Reisaeter, L.M. Irgens and R.T. Lie (2001) Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 323 1213-1217.
212. E.F. Funai, Y. Friedlander, O. Paltiel, E. Tiram, X. Xue, L. Deutsch and S. Harlap (2005) Long-term mortality after preeclampsia. Epidemiology 16 206-215.
213. L. Bellamy, J.P. Casas, A.D. Hingorani and D.J. Williams (2007) Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335 974.
214. L.C. Chesley (1980) Hypertension in pregnancy: Definitions, familial factor, and remote prognosis. Kidney Int 18 234-240.
215. K.A. Fisher, A. Luger, B.H. Spargo and M.D. Lindheimer (1981) Hypertension in pregnancy: clinical-pathological correlations and remote prognosis. Medicine 60 267-276.
216. A. Pouta, A.-L. Hartikainen, U. Sovio, et al. (2004) Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension 43 825-831.
217. J.C. Chambers, L. Fusi, I.S. Malik, D.O. Haskard, M. De Swiet and J.S. Kooner (2001) Association of maternal endothelial dysfunction with preeclampsia. JAMA 285 1607-1612.
218. P.K. Agatisa, R.B. Ness, J.M. Roberts, J.P. Costantino, L.H. Kuller and M.K. McLaughlin (2004) Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol 286 1389-1393.
219. J.E. Ramsay, F. Stewart, I.A. Greer and N. Sattar (2003) Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease. BJOG 110 1029-1031.
220. C.A. Hubel, R.W. Powers, S. Snaedal, H.S. Gammill, R.B. Ness, J.M. Roberts and R. Arngrimsson (2008) C-reactive protein is elevated 30 years after eclamptic pregnancy. Hypertension 51 1499-1505.
221. S. He, A. Silveira, A. Hamsten, M. Blomback and K. Bremme (1999) Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia. Thromb Haemost 81 538-542.
222. A. Barden (2006) Pre-eclampsia: contribution of maternal constitutional factors and the consequences for cardiovascular health. Clin Exp Pharmacol Physiol 33 826-830.
223. D.J. Freeman, F. McManus, E.A. Brown, et al. (2004) Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 44 708-714.
224. A. Portelinha, L. Belo, E. Tejera and I. Rebelo (2008) Adhesion molecules (VCAM-1 and ICAM-1) and C-reactive protein in women with a history of preeclampsia. Acta Obstet Gynecol Scand 87 969-971.
225. B.E. Vikse, L.M. Irgens, T. Leivestad, R. Skjaerven and B.M. Iversen (2008) Preeclampsia and the risk of end-stage renal disease. N Eng J Med 359 800-809.
226. R. Thadhani and C.G. Solomon (2008) Preeclampsia – A glimpse into the future? N Eng J Med 359 858-860.
227. R.M. Mazar, S.K. Srinivas, M.D. Sammel, C.M. Andrela and M.A. Elovitz (2007) Metabolic score as a novel approach to assessing preeclampsia risk. Am J Obstet Gynecol 197 411e1–411e5
228. P.M. Catalano and H.M. Ehrenberg (2006) The short- and long-term implications of maternal obesity on the mother and her offspring. BJOG 113 1126-1133.
229. J.P. Pell, G.C. Smith and D. Walsh (2004) Pregnancy complications and subsequent maternal cerebrovascular events: a retrospective cohort study of 119,668 births. Am J Epidemiol 159 336-342.
230. J.M. Catov, L.M. Bodnar, R.B. Ness, S.J. Barron and J.M. Roberts (2007) Inflammation and dyslipidemia related to risk of spontaneous preterm birth. Am J Epidemiol 166 1312-1319.
231. A.M. Germain, M.C. Romanik, I. Guerra, et al. (2007) Endothelial Dysfunction. A link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension 49 1-6.
232. J.G. Ray, M.J. Vermeulen, M.J. Schull and D.A. Redelmeier (2005) Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 366 1797-1803.
233. A.L. Berends, C.J. de Groot, E.J. Sijbrands, et al. (2008) Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease. Hypertension 51 1034-1041.
234. B.L. Sheppard and J. Bonnar (1981) An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. Br J Obstet Gynaecol 88 695-705.
235. A.C. Staff, T. Ranheim, J. Khoury and T. Henriksen (1999) Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia. Am J Obstet Gynecol 180 587-592.
236. R.W. Powers, R.E. Gandley, D.L. Lykins and J.M. Roberts (2004) Moderate hyperhomocysteinemia decreases endothelial-dependent vasorelaxation in pregnant but not nonpregnant mice. Hypertension 44 327-333.
237. M.M. Faas, G.A. Schuiling, J.F. Baller, C.A. Visscher and W.W. Bakker (1994) A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 171 158-164.
238. J. Martinez-Orgado, R. Gonzalez, S. Tovar, J. Marin, M. Salaices and M.J. Alonso (2003) Administration of N(omega)-L-arginine methyl ester (L-NAME) impairs endothelium-dependent relaxation in gravid but not nongravid rats. J Soc Gynecol Investig 10 74-81.
239. R.J. Ramirez, C.A. Hubel, J. Novak, J.R. DiCianno, V.E. Kagan and R.E. Gandley (2006) Moderate ascorbate deficiency increases myogenic tone of arteries from pregnant but not virgin ascorbate-dependent rats. Hypertension 47 454-460.
240. J.G. Ray, P. Diamond, G. Singh and C.M. Bell (2006) Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG 113 379-386.
241. J.G. Ray (2004) Dysmetabolic syndrome, placenta-mediated disease and future risk of cardiovascular disease. Fetal Matern Med Rev 15 231-246.
242. H.S. Gammill, C. Lin and C.A. Hubel (2007) Endothelial progenitor cells and preeclampsia. Front Biosci 12 2383-2394.
243. N. Sattar, I.A. Greer, P.J. Galloway, C.J. Packard, J. Shepherd, T. Kelly and A. Mathers (1999) Lipid and lipoprotein concentrations in pregnancies complicated by intrauterine growth restriction. J Clin Endocrinol Metab 84 128-130.
244. J.E. Ramsay, W.R. Ferrell, L. Crawford, A.M. Wallace, I.A. Greer and A. Sattar (2004) Divergent metabolic and vascular phenotypes in pre-eclampsia and intrauterine growth restriction: relevance of adiposity. J Hypertens 22 2177-2183.
245. G. Alvino, V. Cozzi, T. Radaelli, H. Ortega and E.H. Cetin (2008) Maternal and fetal fatty acid profile in normal and IUGR pregnancies with and without preeclampsia. Pediatr Res 64 610-614.
246. A. Karowicz-Bilinska, K. Kedziora-Kornatowska and G. Bartosz (2007) Indices of oxidative stress in pregnancy with fetal growth restriction. Free Radic Res 41 870-873.
247. L.M. Bodnar, R.B. Ness, N. Markovic and J.M. Roberts (2005) The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol 15 475-482.
248. C. Williams and T.M. Coltart (1978) Adipose tissue metabolism in pregnancy: the lipolytic effect of human placental lactogen. Br J Obstet Gynaecol 85 43-46.
249. L.L. Waite, A.K. Atwood and R.N. Taylor (2002) Preeclampsia, an implantation disorder. Rev Endocr Metab Disord 3 151-158.
250. T. Biron-Shental, W.T. Schaiff, C.K. Ratajczak, I. Bildirici, M. Nelson and Y. Sadovsky (2007) Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts. Am J Obstet Gynecol 197 e1-e6.
251. D. Fukumura, A. Ushiyama, D.G. Duda, et al. (2003) Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res 93 e88-e97.